What is wrong with 'being a pill-taker'? The special case of statins
Bibliographic Data
| ID | 2249211 |
|---|---|
| Authors | L Polak (0000-0002-7298-4454, London School of Hygiene & Tropical Medicine, corresponding author) |
| Year | 2017 |
| Volume | 39 |
| Issue | 4 |
| Pages | 599-613 |
| Publication date | 2017-05-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Sociology of Health & Illness (JOURNAL) |
| Journal identifiers | ISSN: 0141-9889 • E-ISSN: 1467-9566 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/1467-9566.12509 |
| PMID | 27862018 |
| OpenAlex | W2554140419 |
| Language | EN |
| Citations received | 12 |
| References cited | 38 |
In an interview study of decision-making about statins, many participants said they took pills regularly, yet described themselves as 'not really pill-takers'. This paper explores this paradox and its implications. The practice of pill-taking itself can constitute a challenge to the presentation of moral adequacy, beyond the potential for rendering stigmatised illnesses visible. Meeting this challenge involves a complex process of calibrating often-conflicting moral imperatives: to be concerned, but not too concerned, over one's health; to be informed, but not over-informed; and deferential but not over-deferential to medical expertise. This calibration reflects a broader tension between rival tropes: embracing medical progress and resisting medicalisation. Participants who take statins present them as unquestionably necessary; 'needing' pills, as opposed to choosing to take them, serves as a defence against the devalued identity of being a pill-taker. However, needing to take statins offers an additional threat to identity, because taking statins is widely perceived to be an alternative strategy to 'choosing a healthy lifestyle'. This perception underpins a responsibilising health promotion discourse that shapes and complicates the work participants do to avoid presenting themselves as 'pill-takers'. The salience of this discourse should be acknowledged where discussions of medicalisation use statins as an example
Aesthetics · Cognitive psychology · Epistemology · Identity (music) · Perception · Pill · Salience (neuroscience) · Sociology · Health Systems, Economic Evaluations, Quality of Life · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare · Philosophy · Psychology · Social Psychology
Therapeutic practices in everyday life
Information or Habit
Dissonance of Choice
What factors influence engagement with primary mental health care services? A qualitative study of service user perspectives in rural communities of Mexico
The Disparate Approaches of General Practitioners to the Pharmaceuticalisation of Cardiovascular Disease Prevention
Temporal Aspects of Adherence to HIV Pre-Exposure Prophylaxis (PrEP)
Conceptualising the experience of health risk
Engagement with advice to reduce cardiovascular risk following a health check programme
Adherence and the Moral Construction of the Self
Rethinking decision-making in the context of preventive medication
Wrangling for health
A qualitative exploration of the prescribing and use of statins in asymptomatic people in Ireland
The Converged Experience of Risk and Disease
Patient adherence to treatment
Coronary heart disease and the management of risk
Short cuts to safety
Current conditions or future risks
‘Prevention is better than cure, but …’
Healthism and the Medicalization of Everyday Life
Repositioning the patient
The 'limits' of medicalization
Medication, chronic illness and identity
Patient involvement in drug licensing
Resisting medicines
Using Joint Interviews to Add Analytic Value
Sneaky disease
The meaning of medications
The boundaries of the self and the unhealthy other
Moral discourses and pharmaceuticalised governance in households
The tenacity of the coronary candidate
Distributed decision making
Style, discourse and constraint in adjustment to chronic illness
Lay epidemiology and the prevention paradox
Accounts of health and illness
Causality, responsibility and blame - core issues in the cultural construction and subtext of prevention
The rise of surveillance medicine
Prescriptions and proscriptions
Sustained multiplicity in everyday cholesterol reduction
| Unique citing works | 12 |
|---|---|
| Citations per year | 2 |
| Citation span | 2020 - 2025 (6) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 9 |